Genetic Mutations and Family History
106 articles
An Interview with Dr. Tyler Jacks
Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
Learn the Risk Factors
In the first Let’s Learn webinar, Learn the Risk Factors, experts explain how diabetes, genetic mutations, and pancreatitis impact pancreatic cancer.
Families Working Together Against Pancreatic Cancer
Rob Greenstein discusses how Let’s Win helped his family after his sister Jackie was diagnosed with pancreatic cancer.
KRYSTAL-1 Trial Shows Promising Activity in Pancreas and Other GI Cancers
Dr. Tanios Bekaii-Saab reports promising results of the KRYSTAL-1 trial, which targets a KRAS mutation common to pancreatic cancer.
Steven Merlin and Davi D’Agostino Team Up to Help Others
Pancreatic cancer patient advocates Steven Merlin and Davi D’Agostino have joined to pool expertise and information for other patients.
A Look at MEK and Autophagy Inhibition
Dr. Conan Kinsey looks at the MEK pathway as way to make immunotherapy more effective for pancreatic cancer patients.
MRI-Guided Radiation: A New Option for Pancreatic Cancer Treatment
Dr. Parag Parikh and others are using MRI-guided radiation to provide precision radiation treatment for pancreatic cancer.
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.
In the Fight Against Pancreatic Cancer, Knowledge Is Power
Oncologist Allyson Ocean, M.D., introduces Let’s Win, an interactive website for pancreatic cancer patients to learn about new treatments.
Pancreatic Cancer Risk Factors and Screening
Let’s Win and the National Alliance for Hispanic Health’s Nuestras Voces program held a webinar on risk factors and screening.